FUMIYA YONEYAMA to Aged, 80 and over
This is a "connection" page, showing publications FUMIYA YONEYAMA has written about Aged, 80 and over.
Connection Strength
0.316
-
Real-world trends in the use and outcomes of novel androgen receptor signaling inhibitor therapy in patients with non-metastatic castration-resistant prostate cancer: a multicenter retrospective study. Int J Clin Oncol. 2025 Sep; 30(9):1858-1865.
Score: 0.104
-
Effects of Robot-Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle-Invasive Bladder Cancer: A Multicenter Retrospective Study. Int J Urol. 2025 Aug; 32(8):1007-1013.
Score: 0.102
-
Isolated and Combined Valve Surgery in Elderly Patients: A Comparison of Mid-Term Results. Ann Thorac Cardiovasc Surg. 2017 Jun 20; 23(3):123-127.
Score: 0.058
-
Cross-resistance among novel androgen receptor signaling inhibitors in non-metastatic castration-resistant prostate cancer. Int J Clin Oncol. 2025 Dec; 30(12):2635-2642.
Score: 0.026
-
PD-L1 and Ki-67 Expression Before and After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer. Int J Urol. 2025 Sep; 32(9):1195-1202.
Score: 0.026